NYSE:DVA - Davita Stock Price, Forecast & News

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita Inc (NYSE:DVA) issued its quarterly earnings results on Tuesday, November, 5th. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.24 by $0.29. The company earned $2.90 billion during the quarter, compared to the consensus estimate of $2.85 billion. Davita had a return on equity of 19.95% and a net margin of 3.68%. Davita's revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.56 EPS. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Davita.

Davita updated its FY20 earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $5.25-5.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.32.

9 analysts have issued 12-month target prices for Davita's stock. Their forecasts range from $57.00 to $80.00. On average, they expect Davita's stock price to reach $66.17 in the next twelve months. This suggests that the stock has a possible downside of 16.7%. View Analyst Price Targets for Davita.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

News coverage about DVA stock has been trending positive on Monday, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Davita earned a news impact score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Davita.

Davita saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 8,180,000 shares, an increase of 6.6% from the November 28th total of 7,670,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the days-to-cover ratio is presently 5.2 days. Currently, 6.5% of the shares of the stock are sold short. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Micron Technology (MU), Designer Brands (DBI), United Rentals (URI) and Accenture (ACN).

Davita's stock is owned by many different of institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.47%), Assenagon Asset Management S.A. (0.12%), Bowling Portfolio Management LLC (0.03%), Nisa Investment Advisors LLC (0.02%), Baxter Bros Inc. (0.02%) and Baxter Bros Inc. (0.02%). Company insiders that own Davita stock include Charles Berg, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Stonebridge Capital Management Inc., CenturyLink Investment Management Co, State of Alaska Department of Revenue, IFM Investors Pty Ltd and Louisiana State Employees Retirement System. View Insider Buying and Selling for Davita.

DVA stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Bowling Portfolio Management LLC, Baxter Bros Inc., Baxter Bros Inc., Calamos Advisors LLC, First Hawaiian Bank, Camelot Portfolios LLC and DNB Asset Management AS. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $79.47.

Davita has a market capitalization of $10.18 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]